A fixed-dose, triple-combination CAB topical formulation demonstrated efficacy and safety in both adult and pediatric patients with acne.

Older age is linked to shorter intervals between the diagnosis of PsO and PsA.

AD patients have an increased risk of impaired mobility if they are male or aged 40 to 59 years.

High sodium intake is linked to an increased risk of AD and AD severity

Patients with HS are at an increased risk of anxiety disorders.

Isotretinoin is effective and well tolerated in transgender individuals with acne receiving masculinizing gender-affirming hormonal therapy.

Older adults taking antihypertensive drugs are at an increased risk of eczematous dermatitis.

Daily crisaborole ointment was efficacious in treating mild-to-moderate AD long-term